Try our Advanced Search for more refined results
September 10, 2020
LAVVAN, Inc. v. Amyris, Inc.
Case Number:
1:20-cv-07386
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
September 15, 2022
2nd Circ. Won't Push $881M Cannabis IP Fight Into Arbitration
The Second Circuit on Thursday affirmed a lower court's decision rebuffing biotechnology company Amyris' arbitration bid in cannabinoid maker Lavvan's $881 million patent and trade secrets suit over cannabis development, ruling that a research agreement between the companies doesn't clearly warrant the arbitration.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login